NR4A1 and renal cell carcinoma: In summary, our results show that NR4A1 is pro-oncogenic in RCC and regulates at least three pathways (Fig 1A) important for cell proliferation and survival, and these can be targeted by C-DIM/NR4A1 antagonists.